Search research articles
Contact Us
Filters
Showing results (51-60 of 56) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 56 results.
Hepatology (Baltimore, Md.)
|
November 26, 1998
Better efficacy of a 12-month interferon alfa-2b retreatment in patients with chronic hepatitis C relapsing after a 6-month treatment: a multicenter, controlled, randomized trial. Le Groupe D'étude et De Traitement du Virus De L'hépatite C (Get.Vhc)
J L Payen, J Izopet, V Galindo-Migeot, et al.
Gut
|
August 8, 2006
Treatment of experimental murine pancreatic peritoneal carcinomatosis with fibroblasts genetically modified to express IL12: a role for peritoneal innate immunity
J M Péron, C Bureau, P Gourdy, et al.
ESMO Gastrointestinal Oncology
|
February 6, 2026
Is survival influenced by metastatic site in synchronous metastatic pancreatic adenocarcinoma (PDAC)? A prospective real-world BACAP study
E Alouani, C Canivet, B Bournet, et al.
Oncogene
|
November 11, 2009
A 'DNA replication' signature of progression and negative outcome in colorectal cancer
M-J Pillaire, J Selves, K Gordien, et al.
Virchows Archiv : an International Journal of Pathology
|
February 8, 2019
National multicentric evaluation of quality of pathology reports for rectal cancer in France in 2016
C Boutanos, M Capdepont, M Svrcek, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 2025
Sarcomas developed in patients with Lynch Syndrome are enriched in pleomorphic soft-tissue sarcomas and are sensitive to immunotherapy
F Poumeaud, T Valentin, N Fares, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 56) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 56 results.
Hepatology (Baltimore, Md.)
|
November 26, 1998
Better efficacy of a 12-month interferon alfa-2b retreatment in patients with chronic hepatitis C relapsing after a 6-month treatment: a multicenter, controlled, randomized trial. Le Groupe D'étude et De Traitement du Virus De L'hépatite C (Get.Vhc)
J L Payen, J Izopet, V Galindo-Migeot, et al.
Gut
|
August 8, 2006
Treatment of experimental murine pancreatic peritoneal carcinomatosis with fibroblasts genetically modified to express IL12: a role for peritoneal innate immunity
J M Péron, C Bureau, P Gourdy, et al.
ESMO Gastrointestinal Oncology
|
February 6, 2026
Is survival influenced by metastatic site in synchronous metastatic pancreatic adenocarcinoma (PDAC)? A prospective real-world BACAP study
E Alouani, C Canivet, B Bournet, et al.
Oncogene
|
November 11, 2009
A 'DNA replication' signature of progression and negative outcome in colorectal cancer
M-J Pillaire, J Selves, K Gordien, et al.
Virchows Archiv : an International Journal of Pathology
|
February 8, 2019
National multicentric evaluation of quality of pathology reports for rectal cancer in France in 2016
C Boutanos, M Capdepont, M Svrcek, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 2025
Sarcomas developed in patients with Lynch Syndrome are enriched in pleomorphic soft-tissue sarcomas and are sensitive to immunotherapy
F Poumeaud, T Valentin, N Fares, et al.
Page
of 6